Introduced
by
To require all pharmacies, manufacturers, and wholesale distributors to designate a pharmacist in charge, and provide penalties. This relates to a recent “drug compounding” scandal in New England that led to contaminated drugs causing meningitis in several people.
Referred to the Committee on Health Policy
Reported without amendment
With the recommendation that the substitute (S-2) be adopted and that the bill then pass.
Substitute offered
The substitute passed by voice vote
Passed in the Senate 38 to 0 (details)
Referred to the Committee on Regulatory Reform
Reported without amendment
With the recommendation that the amendments be adopted and that the bill then pass.
Passed in the House 110 to 0 (details)
To require all pharmacies, manufacturers, and wholesale distributors to designate a pharmacist in charge, and provide penalties. This relates to a recent “drug compounding” scandal in New England that led to contaminated drugs causing meningitis in several people.
Passed in the Senate 38 to 0 (details)
To concur with the House-passed version of the bill.
